XML 57 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and contingencies (Details)
€ in Thousands, claim in Thousands, $ in Thousands
1 Months Ended 9 Months Ended 12 Months Ended
Mar. 29, 2019
USD ($)
Dec. 14, 2017
USD ($)
May 31, 2017
subsidiary
Sep. 30, 2020
USD ($)
item
Dec. 31, 2018
EUR (€)
Dec. 31, 2017
EUR (€)
Jul. 31, 2015
USD ($)
claim
Commitments and contingencies              
Number of U.S. FDA Pending Warning Letters | item       1      
Foreign Corrupt Practices Act              
Commitments and contingencies              
FCPA related charge | €         € 77,200 € 200,000  
Legal proceedings provision | €         € 223,980    
FCPA related payment $ 231,700            
Foreign Corrupt Practices Act | Minimum              
Commitments and contingencies              
Independent compliance monitor period (in years) 2 years            
Acid Concentrate Products - Personal Injury              
Commitments and contingencies              
Settlement fund       $ 220,000      
Net litigation settlement expense recorded       60,000      
Amount to be recovered by AIG, if it prevails in all its remaining claims       60,000      
Amount that FMCH claims to recover       $ 108,000      
Hawaii Medicaid False Claims              
Commitments and contingencies              
Amount claimed against company             $ 7,700
Number of claims submitted | claim             20
Management of pharmaceuticals, including Velphoro              
Commitments and contingencies              
Litigation settlement by Davita Rx   $ 63,700          
United States Attorney for the Middle District of Tennessee              
Commitments and contingencies              
Litigation settlement by Davita Rx   $ 63,700          
Number of subsidiaries to which subpoenas were issued | subsidiary     2